Literature DB >> 22035581

Clinical survey of 3680 iris tumors based on patient age at presentation.

Carol L Shields1, Swarupa Kancherla, Jinali Patel, Priya Vijayvargiya, Mayerling M Suriano, Emily Kolbus, Ami Badami, Priya Sharma, Emily Jacobs, Matt Voluck, Zina Zhang, Rishav Kansal, Patrick W Shields, Carlos G Bianciotto, Jerry A Shields.   

Abstract

OBJECTIVE: To report the spectrum of iris lesions based on patient age at presentation.
DESIGN: Retrospective, nonrandomized, single-center case series. PARTICIPANTS: We included 3680 iris tumors in 3451 patients.
METHODS: Chart review. MAIN OUTCOME MEASURES: Diagnostic category based on age.
RESULTS: The mean age at presentation was 48 years and there were 449 (12%) tumors in children (≤20 years), 788 (21%) in young adults (21-40 years), 1308 (36%) in mid adults (41-60 years), and 1135 (31%) in senior adults (>60 years). Of 3680 tumors, the diagnostic category was cystic (n = 768; 21%) or solid (n = 2912; 79%). The cystic tumors originated from iris pigment epithelium (IPE; n = 672; 18%) or iris stroma (n = 96; 3%). The solid tumors included melanocytic (n = 2510; 68%) and nonmelanocytic (n = 402; 11%). The melanocytic tumors comprised nevus (n = 1503; 60%), melanocytoma (n = 68; 3%), melanoma (n = 645; 26%), and melanocytosis (n = 64; 3%). Of 2510 melanocytic tumors, the first and second most common diagnoses by age (children, young adult, mid adult, senior adult) were nevus (53%, 57%, 63%, and 63%, respectively) and melanoma (17%, 27%, 26%, and 27%, respectively). The nonmelanocytic tumors included categories of choristomatous (n = 4; <1%), vascular (n = 57; 2%), fibrous (n = 2; <1%), neural (n = 3; <1%), myogenic (n = 2;, <1%), epithelial (n = 35; 1%), xanthomatous (n = 8; <1%), metastasis (n = 67; 2%), lymphoid (n = 12; <1%), leukemic (n = 2; <1%), secondary (n = 12; <1%), and nonneoplastic simulators (n = 198; 5%). The median age (in years) at diagnosis included cystic (39), melanocytic (52), choristomatous (0.7), vascular (56), fibrous (53), neural (8), myogenic (42), epithelial (63), xanthomatous (1.9), metastasis (60), lymphoid (57), leukemic (25.5), secondary (59), and nonneoplastic simulators (49). Overall, the 3 most common specific diagnoses (children, young adult, mid adult, senior adult) were nevus (25%, 36%, 47%, and 47%, respectively), IPE cyst (28%, 30%, 15%, and 14%, respectively), and melanoma (8%, 16%, 20%, and 19%, respectively).
CONCLUSIONS: In an ocular oncology practice, the spectrum of iris tumors includes cystic (21%) and solid (79%) tumors. The solid tumors were melanocytic (68%) or nonmelanocytic (11%). At all ages, the most common specific diagnoses were nevus (42%), IPE cyst (19%), and melanoma (17%).
Copyright © 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22035581     DOI: 10.1016/j.ophtha.2011.07.059

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  32 in total

Review 1.  [New treatment options for iridociliary tumors].

Authors:  J M Mor; K R Koch; V Kakkassery; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2019-04       Impact factor: 1.059

2.  A Case of Metastatic Iris Tumor Observed With Anterior Segment Optical Coherence Tomography Before and After Radiation Therapy.

Authors:  Mizuho Mitamura; Satoru Kase; Yuka Suimon; Takako Ito; Susumu Ishida
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Intravitreal bevacizumab for iris tumor metastasized from large cell neuroendocrine carcinoma of lung.

Authors:  Hirotaka Yokouchi; Masayasu Kitahashi; Toshiyuki Oshitari; Shuichi Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

4.  [Pseudo-tumor of the iris following cataract surgery].

Authors:  T Ristau; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

5.  [Pseudotumor of the cornea in childhood].

Authors:  G Avgitidou; A Zhivov; L M Heindl; C Cursiefen
Journal:  Ophthalmologe       Date:  2014-11       Impact factor: 1.059

6.  Optical Coherence Tomography Angiography Features of Iris Racemose Hemangioma in 4 Cases.

Authors:  Jason L Chien; Kareem Sioufi; Sandor Ferenczy; Emil Anthony T Say; Carol L Shields
Journal:  JAMA Ophthalmol       Date:  2017-10-01       Impact factor: 7.389

Review 7.  The best of the best: a review of select pediatric ophthalmology and strabismus case reports published in 2015.

Authors:  Pavlina S Kemp
Journal:  Digit J Ophthalmol       Date:  2016-11-14

8.  Surgical removal of a giant iris stromal cyst: an intraoperative optical coherence tomography-guided approach.

Authors:  Rajesh Sinha; Manthan Hasmukhbhai Chaniyara; Jayanand Urkude; Amar Pujari
Journal:  BMJ Case Rep       Date:  2017-12-27

9.  An Iris Tumor.

Authors:  Rajesh C Rao; J William Harbour
Journal:  JAMA Ophthalmol       Date:  2016-09-01       Impact factor: 7.389

Review 10.  [Intraocular metastases].

Authors:  D Westerwick; F Driever; C H D Le Guin; K W Schmid; K A Metz
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.